Home › Aerocrine Resumes Sales and Marketing of Niox Mino in China after Re-Registration Approval
 

Keywords :   


Aerocrine Resumes Sales and Marketing of Niox Mino in China after Re-Registration Approval

2014-12-15 11:14:35| Appliances - Topix.net

Aerocrine AB , a leader in products to monitor and manage airway inflammation associated with Asthma, announced today that its handheld airway inflammation monitoring device, NIOX MINO, has been re-registered for marketing and sales by the China Food and Drug Administration . The approval means that Aerocrine and its partners can now resume its sales and marketing activities of NIOX MINO and grow the deployed base in the Chinese market.

Tags: sales china marketing approval

Category:Consumer Goods and Services

Latest from this category

All news
27.11Interra adds Netflix VMAF video quality assessment support
27.11Brightcove to be acquired by Bending Spoons
27.11FOX, Disney capitalize on multiplatform TV footprint in October
27.11Tele Columbus TV households down 40% YoY in 3Q 2024
27.11'It's going to be hard': US firms race to get ahead of Trump tariffs
27.11Loyalty cards offer genuine savings, says watchdog
27.11Aston Martin issues second profit warning in two months
27.11Online slots gambling to be limited to 5 per spin
Consumer Goods and Services »
28.11
28.11240
28.11 C.J.Date
28.11VR7001
28.11BEAST
28.11
28.11
28.11 112
More »